Merkel cell polyomavirus infection and Merkel cell carcinoma

Current Opinion in Virology

Volumn 20, Issue , 2016, Pages 20-27

  Liu, Wei ^a   MacDonald, Margo ^a   You, Jianxin ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL TRANSFORMATION; HOST CELL; HUMAN; IMMUNE RESPONSE; MERKEL CELL POLYOMAVIRUS; MERKEL CELL POLYOMAVIRUS INFECTION; MERKEL CELL TUMOR; NONHUMAN; PERSISTENT INFECTION; POLYOMAVIRUS INFECTION; PRIORITY JOURNAL; REVIEW; TARGET CELL; VIRUS ONCOGENE; CARCINOGENESIS; COMPLICATION; HOST PATHOGEN INTERACTION; IMMUNOLOGY; MERKEL CELL CARCINOMA; PATHOGENICITY; PATHOPHYSIOLOGY; VIRUS INFECTION;

CARCINOGENESIS; CARCINOMA, MERKEL CELL; HOST-PATHOGEN INTERACTIONS; HUMANS; MERKEL CELL POLYOMAVIRUS; POLYOMAVIRUS INFECTIONS; TUMOR VIRUS INFECTIONS;

EID: 84981210846     PISSN: 18796257     EISSN: 18796265     Source Type: Journal    
DOI: 10.1016/j.coviro.2016.07.011     Document Type: Review

References (74)

1. 1•• Feng, H., Shuda, M., Chang, Y., Moore, P.S., Clonal integration of a polyomavirus in human Merkel cell carcinoma. Science 319 (2008), 1096–1100 This study discovers the presence of MCPyV in 80% of MCC tumors and suggests MCPyV is a contributing factor to MCC tumorigenesis.
2. 2 Lemos, B.D., Storer, B.E., Iyer, J.G., Phillips, J.L., Bichakjian, C.K., Fang, L.C., Johnson, T.M., Liegeois-Kwon, N.J., Otley, C.C., Paulson, K.G., et al. Pathologic nodal evaluation improves prognostic accuracy in Merkel cell carcinoma: analysis of 5823 cases as the basis of the first consensus staging system. J Am Acad Dermatol 63 (2010), 751–761.
3. 3 Lemos, B., Nghiem, P., Merkel cell carcinoma: more deaths but still no pathway to blame. J Invest Dermatol 127 (2007), 2100–2103.
4. 4 Weinstock, M.A., Gardstein, B., Twenty-year trends in the reported incidence of mycosis fungoides and associated mortality. Am J Public Health 89 (1999), 1240–1244.
5. 5 Engels, E.A., Frisch, M., Goedert, J.J., Biggar, R.J., Miller, R.W., Merkel cell carcinoma and HIV infection. Lancet 359 (2002), 497–498.
6. 6 Locke, F.L., Rollison, D.E., Sondak, V.K., Merkel cell carcinoma and immunosuppression: what we still need to know. J Natl Cancer Inst, 2015, 107.
7. 7•• Chang, Y., Moore, P.S., Merkel cell carcinoma: a virus-induced human cancer. Annu Rev Pathol 7 (2012), 123–144 This review discusses the genomic organization of MCPyV, the molecular biology and pathology of both MCPyV and MCC, and the epidemiology of MCPyV and MCC.
8. 8• Tolstov, Y.L., Pastrana, D.V., Feng, H., Becker, J.C., Jenkins, F.J., Moschos, S., Chang, Y., Buck, C.B., Moore, P.S., Human Merkel cell polyomavirus infection II. MCV is a common human infection that can be detected by conformational capsid epitope immunoassays. Int J Cancer 125 (2009), 1250–1256 This study shows that, although it was previously unrecognized, MCPyV infection is widespread in the human population, and that MCC patients have elevated MCPyV IgG response compared to controls.
9. 9•• Schowalter, R.M., Pastrana, D.V., Pumphrey, K.A., Moyer, A.L., Buck, C.B., Merkel cell polyomavirus and two previously unknown polyomaviruses are chronically shed from human skin. Cell Host Microbe 7 (2010), 509–515 This study isolated complete, wild-type cloned genomes of MCPyV, and also discovered the existence of two previously unknown polyomaviruses, human polyomavirus-6 and human polyomavirus-7.
10. 10 Foulongne, V., Sauvage, V., Hebert, C., Dereure, O., Cheval, J., Gouilh, M.A., Pariente, K., Segondy, M., Burguière, A., Manuguerra, J.-C., et al. Human skin microbiota: high diversity of DNA viruses identified on the human skin by high throughput sequencing. PLoS ONE, 7, 2012, e38499.
11. 11 Kean, J.M., Rao, S., Wang, M., Garcea, R.L., Seroepidemiology of human polyomaviruses. PLoS Pathog, 5, 2009, e1000363.
12. 12 Pastrana, D.V., Tolstov, Y.L., Becker, J.C., Moore, P.S., Chang, Y., Buck, C.B., Quantitation of human seroresponsiveness to Merkel cell polyomavirus. PLoS Pathog, 5, 2009, e1000578.
13. 13 Chen, T., Hedman, L., Mattila, P.S., Jartti, T., Ruuskanen, O., Soderlund-Venermo, M., Hedman, K., Serological evidence of Merkel cell polyomavirus primary infections in childhood. J Clin Virol 50 (2011), 125–129.
14. 14 Gjoerup, O., Chang, Y., Update on human polyomaviruses and cancer. George, F.V.W., (eds.) Advances in Cancer Research, vol 106, 2010, Academic Press, George K, 1–51 [Chapter 1].
15. 15 Johne, R., Buck, C.B., Allander, T., Atwood, W.J., Garcea, R.L., Imperiale, M.J., Major, E.O., Ramqvist, T., Norkin, L.C., Taxonomical developments in the family Polyomaviridae. Arch Virol 156 (2011), 1627–1634.
16. 16•• Shuda, M., Feng, H., Kwun, H.J., Rosen, S.T., Gjoerup, O., Moore, P.S., Chang, Y., T antigen mutations are a human tumor-specific signature for Merkel cell polyomavirus. Proc Natl Acad Sci U S A 105 (2008), 16272–16277 This article shows that LT antigen is truncated in MCC tumor cells, eliminating viral DNA replication capacity by removing the origin binding and helicase domains, preventing autoactivation of integrated virus replication that would threaten cell survival.
17. 17•• Carter, J.J., Daugherty, M.D., Qi, X., Bheda-Malge, A., Wipf, G.C., Robinson, K., Roman, A., Malik, H.S., Galloway, D.A., Identification of an overprinting gene in Merkel cell polyomavirus provides evolutionary insight into the birth of viral genes. Proc Natl Acad Sci U S A 110 (2013), 12744–12749 This article identifies an overprinting gene, alternate LT ORF (ALTO), in MCPyV and other polyomaviruses.
18. 18 Schowalter, R.M., Buck, C.B., The Merkel cell polyomavirus minor capsid protein. PLoS Pathog, 9, 2013, e1003558.
19. 19 Busam, K.J., Jungbluth, A.A., Rekthman, N., Coit, D., Pulitzer, M., Bini, J., Arora, R., Hanson, N.C., Tassello, J.A., Frosina, D., et al. Merkel cell polyomavirus expression in merkel cell carcinomas and its absence in combined tumors and pulmonary neuroendocrine carcinomas. Am J Surg Pathol 33 (2009), 1378–1385.
20. 20• Houben, R., Shuda, M., Weinkam, R., Schrama, D., Feng, H., Chang, Y., Moore, P.S., Becker, J.C., Merkel cell polyomavirus-infected Merkel cell carcinoma cells require expression of viral T antigens. J Virol 84 (2010), 7064–7072 This article shows that viral T antigen expression is necessary for the maintenance of MCPyV-positive MCC. This study provides direct evidence that MCPyV is the infectious cause of MCPyV-positive MCC.
21. 21 Shuda, M., Arora, R., Kwun, H.J., Feng, H., Sarid, R., Fernandez-Figueras, M.T., Tolstov, Y., Gjoerup, O., Mansukhani, M.M., Swerdlow, S.H., et al. Human Merkel cell polyomavirus infection I. MCV T antigen expression in Merkel cell carcinoma, lymphoid tissues and lymphoid tumors. Int J Cancer 125 (2009), 1243–1249.
22. 22 Shuda, M., Kwun, H.J., Feng, H., Chang, Y., Moore, P.S., Human Merkel cell polyomavirus small T antigen is an oncoprotein targeting the 4E-BP1 translation regulator. J Clin Invest 121 (2011), 3623–3634.
23. 23 Rodig, S.J., Cheng, J., Wardzala, J., DoRosario, A., Scanlon, J.J., Laga, A.C., Martinez-Fernandez, A., Barletta, J.A., Bellizzi, A.M., Sadasivam, S., et al. Improved detection suggests all Merkel cell carcinomas harbor Merkel polyomavirus. J Clin Invest 122 (2012), 4645–4653.
24. 24 Amber, K., McLeod, M.P., Nouri, K., The Merkel cell polyomavirus and its involvement in Merkel cell carcinoma. Dermatol Surg 39 (2013), 232–238.
25. 25 Laude, H.C., Jonchere, B., Maubec, E., Carlotti, A., Marinho, E., Couturaud, B., Peter, M., Sastre-Garau, X., Avril, M.F., Dupin, N., et al. Distinct merkel cell polyomavirus molecular features in tumour and non tumour specimens from patients with merkel cell carcinoma. PLoS Pathog, 6, 2010, e1001076.
26. 26 de Biase, D., Ragazzi, M., Asioli, S., Eusebi, V., Extracutaneous Merkel cell carcinomas harbor polyomavirus DNA. Hum Pathol 43 (2012), 980–985.
27. 27 Sastre-Garau, X., Peter, M., Avril, M.F., Laude, H., Couturier, J., Rozenberg, F., Almeida, A., Boitier, F., Carlotti, A., Couturaud, B., et al. Merkel cell carcinoma of the skin: pathological and molecular evidence for a causative role of MCV in oncogenesis. J Pathol 218 (2009), 48–56.
28. 28 Hodgson, N.C., Merkel cell carcinoma: changing incidence trends. J Surg Oncol 89 (2005), 1–4.
29. 29•• Grundhoff, A., Fischer, N., Merkel cell polyomavirus, a highly prevalent virus with tumorigenic potential. Curr Opin Virol 14 (2015), 129–137 This review discusses MCPyV biology and the unique features that distinguish MCPyV from other polyomaviruses.
30. 30 Wendzicki, J.A., Moore, P.S., Chang, Y., Large T and small T antigens of Merkel cell polyomavirus. Curr Opin Virol 11 (2015), 38–43.
31. 31 Spurgeon, M.E., Lambert, P.F., Merkel cell polyomavirus: a newly discovered human virus with oncogenic potential. Virology 435 (2013), 118–130.
32. 32 Borchert, S., Czech-Sioli, M., Neumann, F., Schmidt, C., Wimmer, P., Dobner, T., Grundhoff, A., Fischer, N., High-affinity Rb binding, p53 inhibition, subcellular localization, and transformation by wild-type or tumor-derived shortened Merkel cell polyomavirus large T antigens. J Virol 88 (2014), 3144–3160.
33. 33 Houben, R., Adam, C., Baeurle, A., Hesbacher, S., Grimm, J., Angermeyer, S., Henzel, K., Hauser, S., Elling, R., Brocker, E.B., et al. An intact retinoblastoma protein-binding site in Merkel cell polyomavirus large T antigen is required for promoting growth of Merkel cell carcinoma cells. Int J Cancer 130 (2012), 847–856.
34. 34• Verhaegen, M.E., Mangelberger, D., Harms, P.W., Vozheiko, T.D., Weick, J.W., Wilbert, D.M., Saunders, T.L., Ermilov, A.N., Bichakjian, C.K., Johnson, T.M., et al. Merkel cell polyomavirus small T antigen is oncogenic in transgenic mice. J Invest Dermatol, 2014 This article demonstrates transforming activity of MCPyV sT antigen in vivo using a panel of transgenic mouse models. The result implicates sT antigen as an oncogenic driver in MCC.
35. Fbw7 E3 ligase that targets LT for proteasomal degradation.
36. 36 Houben, R., Schrama, D., Becker, J.C., Molecular pathogenesis of Merkel cell carcinoma. Exp Dermatol 18 (2009), 193–198.
37. 37• Li, J., Wang, X., Diaz, J., Tsang, S.H., Buck, C.B., You, J., Merkel cell polyomavirus large T antigen disrupts host genomic integrity and inhibits cellular proliferation. J Virol 87 (2013), 9173–9188 PMCID: PMC3957940 This article shows that the helicase-containing region of the MCPyV LT activates host DNA damage responses and enhanced p53 phosphorylation, thus contributing to the full-length LT antitumorigenic activity.
38. 38• Cheng, J., Rozenblatt-Rosen, O., Paulson, K.G., Nghiem, P., DeCaprio, J.A., Merkel cell polyomavirus large T antigen has growth-promoting and inhibitory activities. J Virol 87 (2013), 6118–6126 This article shows that MCPyV LT has both growth-promoting and inhibitory properties, depending on whether or not its C terminus has been truncated. This study also mapped the MCPyV large T growth-inhibitory function to the C-terminal 100 residues region.
39. 39 Li, J., Diaz, J., Wang, X., Tsang, S.H., You, J., Phosphorylation of Merkel cell polyomavirus large tumor antigen at serine 816 by ATM kinase induces apoptosis in host cells. J Biol Chem 290 (2015), 1874–1884.
40. 40 Feng, H., Kwun, H.J., Liu, X., Gjoerup, O., Stolz, D.B., Chang, Y., Moore, P.S., Cellular and viral factors regulating Merkel cell polyomavirus replication. PLoS ONE, 6, 2011, e22468.
41. 41 Schowalter, R.M., Pastrana, D.V., Buck, C.B., Glycosaminoglycans and sialylated glycans sequentially facilitate Merkel cell polyomavirus infectious entry. PLoS Pathog, 7, 2011, e1002161.
42. 42 Neumann, F., Borchert, S., Schmidt, C., Reimer, R., Hohenberg, H., Fischer, N., Grundhoff, A., Replication, gene expression and particle production by a consensus Merkel cell polyomavirus (MCPyV) genome. PLoS ONE, 6, 2011, e2911f2.
43. 43 Schowalter, R.M., Reinhold, W.C., Buck, C.B., Entry tropism of BK and Merkel cell polyomaviruses in cell culture. PLoS ONE, 7, 2012, e42181.
44. 44 Tsang, S.H., Wang, X., Li, J., Buck, C.B., You, J., Host DNA damage response factors localize to merkel cell polyomavirus DNA replication sites to support efficient viral DNA replication. J Virol 88 (2014), 3285–3297 PMCID: PMC3957940.
45. 45•• Liu, W., Yang, R., Payne, A.S., Schowalter, R.M., Spurgeon, M.E., Lambert, P.F., Xu, X., Buck, C.B., You, J., Identifying the target cells and mechanisms of Merkel cell polyomavirus infection. Cell Host Microbe, 2016 This article identifies human dermal fibroblasts as the natural host cells supporting productive MCPyV infection. It shows that induction of matrix metalloproteinase genes by the WNT/β-catenin signaling pathway stimulates viral infection, identifying MEK antagonist trametinib as an effective inhibitor.
46. 46 Tilling, T., Moll, I., Which are the cells of origin in Merkel cell carcinoma?. J Skin Cancer, 2012, 2012, 680410.
47. 47 Vaigot, P., Pisani, A., Darmon, Y.M., Ortonne, J.P., The majority of epidermal Merkel cells are non-proliferative: a quantitative immunofluorescence analysis. Acta Derm Venereol 67 (1987), 517–520.
48. 48 Moll, I., Zieger, W., Schmelz, M., Proliferative Merkel cells were not detected in human skin. Arch Dermatol Res 288 (1996), 184–187.
49. 49 Morrison, K.M., Miesegaes, G.R., Lumpkin, E.A., Maricich, S.M., Mammalian Merkel cells are descended from the epidermal lineage. Dev Biol 336 (2009), 76–83.
50. 50 Van Keymeulen, A., Mascre, G., Youseff, K.K., Harel, I., Michaux, C., De Geest, N., Szpalski, C., Achouri, Y., Bloch, W., Hassan, B.A., et al. Epidermal progenitors give rise to Merkel cells during embryonic development and adult homeostasis. J Cell Biol 187 (2009), 91–100.
51. 51 Calder, K.B., Smoller, B.R., New insights into merkel cell carcinoma. Adv Anat Pathol 17 (2010), 155–161.
52. 52•• Zur Hausen, A., Rennspiess, D., Winnepenninckx, V., Speel, E.J., Kurz, A.K., Early B-cell differentiation in Merkel cell carcinomas: clues to cellular ancestry. Cancer Res, 2013 This article shows that all MCC tumors tested expressed PAX5, and many expressed TdT. This coexpression is restricted to pro/pre-B and pre-B cells under physiologic circumstances, indicating that MCCs possibly derive from these cells rather than Merkel cells.
53. 53• Harms, P.W., Patel, R.M., Verhaegen, M.E., Giordano, T.J., Nash, K.T., Johnson, C.N., Daignault, S., Thomas, D.G., Gudjonsson, J.E., Elder, J.T., et al. Distinct gene expression profiles of viral- and nonviral-associated merkel cell carcinoma revealed by transcriptome analysis. J Invest Dermatol 133 (2013), 936–945 This article shows the result of a DNA microarray analysis comparing the gene expression profiles of MCPyV-negative and MCPyV-positive MCC tumors, suggesting that loss of RB1 expression may be a critical contributing factor for MCPyV-negative tumorigenesis.
54. 54 Ma, J.E., Brewer, J.D., Merkel cell carcinoma in immunosuppressed patients. Cancers (Basel) 6 (2014), 1328–1350.
55. 55 Triozzi, P.L., Fernandez, A.P., The role of the immune response in Merkel cell carcinoma. Cancers (Basel) 5 (2013), 234–254.
56. 56 Sihto, H., Bohling, T., Kavola, H., Koljonen, V., Salmi, M., Jalkanen, S., Joensuu, H., Tumor infiltrating immune cells and outcome of Merkel cell carcinoma: a population-based study. Clin Cancer Res 18 (2012), 2872–2881.
57. 57 Paulson, K.G., Iyer, J.G., Tegeder, A.R., Thibodeau, R., Schelter, J., Koba, S., Schrama, D., Simonson, W.T., Lemos, B.D., Byrd, D.R., et al. Transcriptome-wide studies of merkel cell carcinoma and validation of intratumoral CD8+ lymphocyte invasion as an independent predictor of survival. J Clin Oncol 29 (2011), 1539–1546.
58. 58 Sihto, H., Joensuu, H., Tumor-infiltrating lymphocytes and outcome in Merkel cell carcinoma, a virus-associated cancer. Oncoimmunology 1 (2012), 1420–1421.
59. 59 Heath, M., Jaimes, N., Lemos, B., Mostaghimi, A., Wang, L.C., Peñas, P.F., Nghiem, P., Clinical characteristics of Merkel cell carcinoma at diagnosis in 195 patients: the AEIOU features. J Am Acad Dermatol 58 (2008), 375–381.
60. 60 Iyer, J.G., Afanasiev, O.K., McClurkan, C., Paulson, K., Nagase, K., Jing, L., Marshak, J.O., Dong, L., Carter, J., Lai, I., et al. Merkel cell polyomavirus-specific CD8(+) and CD4(+) T-cell responses identified in Merkel cell carcinomas and blood. Clin Cancer Res 17 (2011), 6671–6680.
61. 61•• Paulson, K.G., Tegeder, A., Willmes, C., Iyer, J.G., Afanasiev, O.K., Schrama, D., Koba, S., Thibodeau, R., Nagase, K., Simonson, W.T., et al. Downregulation of MHC-I expression is prevalent but reversible in Merkel cell carcinoma. Cancer Immunol Res 2 (2014), 1071–1079 This article demonstrates MHC-1 downregulation in MCC tumors, especially those infected with MCPyV. The downregulation was multifactorial, depending on more than just HLA gene expression, but was reversible with interferon treatment.
62. 62 Shahzad, N., Shuda, M., Gheit, T., Kwun, H.J., Cornet, I., Saidj, D., Zannetti, C., Hasan, U., Chang, Y., Moore, P.S., et al. The T antigen locus of Merkel cell polyomavirus downregulates human Toll-like receptor 9 expression. J Virol 87 (2013), 13009–13019.
63. 63• Griffiths, D.A., Abdul-Sada, H., Knight, L.M., Jackson, B.R., Richards, K., Prescott, E.L., Peach, A.H., Blair, G.E., Macdonald, A., Whitehouse, A., Merkel cell polyomavirus small T antigen targets the NEMO adaptor protein to disrupt inflammatory signaling. J Virol 87 (2013), 13853–13867 This article shows that MCPyV sT inhibits NF-κB-mediated cellular gene transcription, allowing MCPyV to subvert the innate immune response.
64. 64 Houben, R., Angermeyer, S., Haferkamp, S., Aue, A., Goebeler, M., Schrama, D., Hesbacher, S., Characterization of functional domains in the Merkel cell polyoma virus large T antigen. Int J Cancer 136 (2015), E290–E300.
65. 65 Martel-Jantin, C., Filippone, C., Cassar, O., Peter, M., Tomasic, G., Vielh, P., Briere, J., Petrella, T., Aubriot-Lorton, M.H., Mortier, L., et al. Genetic variability and integration of Merkel cell polyomavirus in Merkel cell carcinoma. Virology 426 (2012), 134–142.
66. 66 Zur Hausen, A., Rennspiess, D., Winnepenninckx, V., Speel, E.J., Kurz, A.K., Early B-cell differentiation in Merkel cell carcinomas: clues to cellular ancestry. Cancer Res 73 (2013), 4982–4987.
67. 67 Ratner, D., Nelson, B.R., Brown, M.D., Johnson, T.M., Merkel cell carcinoma. J Am Acad Dermatol 29 (1993), 143–156.
68. 68 Leff, E.L., Brooks, J.S., Trojanowski, J.Q., Expression of neurofilament and neuron-specific enolase in small cell tumors of skin using immunohistochemistry. Cancer 56 (1985), 625–631.
69. 69 Chan, J.K., Suster, S., Wenig, B.M., Tsang, W.Y., Chan, J.B., Lau, A.L., Cytokeratin 20 immunoreactivity distinguishes Merkel cell (primary cutaneous neuroendocrine) carcinomas and salivary gland small cell carcinomas from small cell carcinomas of various sites. Am J Surg Pathol 21 (1997), 226–234.
70. 70 Tang, C.K., Toker, C., Trabecular carcinoma of the skin: an ultrastructural study. Cancer 42 (1978), 2311–2321.
71. 71 Moll, I., Kuhn, C., Moll, R., Cytokeratin 20 is a general marker of cutaneous Merkel cells while certain neuronal proteins are absent. J Invest Dermatol 104 (1995), 910–915.
72. 72 Gore, S.D., Kastan, M.B., Civin, C.I., Normal human bone marrow precursors that express terminal deoxynucleotidyl transferase include T-cell precursors and possible lymphoid stem cells. Blood 77 (1991), 1681–1690.
73. 73 Adams, B., Dorfler, P., Aguzzi, A., Kozmik, Z., Urbanek, P., Maurer-Fogy, I., Busslinger, M., Pax-5 encodes the transcription factor BSAP and is expressed in B lymphocytes, the developing CNS, and adult testis. Genes Dev 6 (1992), 1589–1607.
74. 74 Liu, W., Yang, R., Payne, A.S., Schowalter, R.M., Spurgeon, M.E., Lambert, P.F., Xu, X., Buck, C.B., You, J., Identifying the target cells and mechanisms of Merkel cell polyomavirus infection. Cell Host Microbe 19 (2016), 775–787.